CoChat

Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis

Open access
Higashiyama, Masaaki, Tomita, Kengo, Sugihara, Nao, Nakashima, Hiroyuki, Furuhashi, Hirotaka, Nishikawa, Makoto, Inaba, Kenichi, Wada, Akinori, Horiuchi, Kazuki, Hanawa, Yoshinori, Shibuya, Naoki, Kurihara, Chie, Okada, Yoshikiyo, Nishii, Shin, Mizoguchi, Akinori, Hozumi, Hideaki, Watanabe, Chikako, Komoto, Shunsuke, Yamamoto, Junji, Seki, Shuhji, Miura, Soichiro, Hokari, Ryota · 2019 · Hepatology Research
Cited by 49

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aim: Chitinase 3‐like 1 (CHI3L1), an 18‐glycosyl hydrolase‐related molecule, is a member of the enzymatically inactive chitinase‐like protein family. Serum levels of CHI3L1 are strongly correlated with hepatic fibrosis progression during many liver diseases. Therefore, this protein could be involved in the development of hepatic fibrosis pathology; however, its role has not been elucidated. We aimed to elucidate its role in the pathophysiology of liver fibrosis. Methods: Chitinase 3‐like 1‐deficient (Chi3l1−/−) mice were given carbon tetrachloride twice per week for 4 weeks or fed a methionine choline‐deficient diet for 12 weeks to generate mouse liver fibrosis models. Human fibrotic liver tissues were also examined immunohistochemically. Results: In human and mouse fibrotic livers, CHI3L1 expression was mainly localized to hepatic macrophages, and the intrahepatic accumulation of CHI3L1+ macrophages was significantly enhanced compared to that in control livers. In the two mouse models, hepatic fibrosis was significantly ameliorated in Chi3l1−/− mice compared to that in wild‐type mice, which was dependent on hepatic macrophages. The accumulation and activation of hepatic macrophages was also significantly suppressed in Chi3l1−/− mice compared to that in wild‐type mice. Furthermore, apoptotic hepatic macrophages were significantly increased in Chi3l1−/− mice. Chitinase 3‐like 1 was found to inhibit hepatic macrophage apoptosis by suppressing Fas expression and activating Akt signaling in an autocrine manner, which resulted in hepatic macrophage accumulation and activation, exaggerating liver fibrosis. Conclusions: Chitinase 3‐like 1 exacerbates liver fibrosis progression by suppressing apoptosis in hepatic macrophages. Therefore, this might be a potential therapeutic target for the treatment of liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hepr.13396

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 49

Metadata

Authors
Higashiyama, M., Tomita, K., Sugihara, N., Nakashima, H., Furuhashi, H., Nishikawa, M., Inaba, K., Wada, A., Horiuchi, K., Hanawa, Y., Shibuya, N., Kurihara, C., Okada, Y., Nishii, S., Mizoguchi, A., Hozumi, H., Watanabe, C., Komoto, S., Yamamoto, J., Seki, S., Miura, S., & Hokari, R.
Venue
Hepatology Research
Publisher
Wiley
Published
2019-07-12
Volume
49
Issue
11
Pages
1316-1328
ISSN
  • 1386-6346 (ISSN-L)
  • 1872-034X
OpenAlex
W2955432337
Cited by
49
References
6
FWCI
2.30
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis. https://app.cochat.ai/papers/10.1111/hepr.13396
The paper
Higashiyama, M., Tomita, K., Sugihara, N., Nakashima, H., Furuhashi, H., Nishikawa, M., Inaba, K., Wada, A., Horiuchi, K., Hanawa, Y., Shibuya, N., Kurihara, C., Okada, Y., Nishii, S., Mizoguchi, A., Hozumi, H., Watanabe, C., Komoto, S., Yamamoto, J., . . . Hokari, R. (2019). Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis. Hepatology Research. https://doi.org/10.1111/hepr.13396

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.